Next 3 months I don't expect any negative news as they prepare to commission the R&D plant inside Q1. In fact I think we'll see the stock slowly rise. I think the new CEO is getting this right. They also didn't give themselves the maximum 10% stock options they were entitled to but instead closer to 2% of their outstanding shares. Plus senior management has strict milestones attached to their options before being granted. Achieving positive results from the R&D plant that will indicate a commercially viable process is all that matters now. This company will be either on life support or flying higher by the end of summer IMO.